About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 42 record(s)
Req # A-2020-001847
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03580788.Organization: Health Canada
June 2021
Req # A-2020-001840
Adverse Drug Reaction (ADR). Report number: E2B_03581369.Organization: Health Canada
June 2021
Req # A-2020-001841
Adverse Drug Reaction (ADR). Report number: E2B_03545704.Organization: Health Canada
June 2021
Req # A-2021-000299
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-104908-893, Meeting with Thoughtwire.Organization: Health Canada
June 2021
Req # A-2020-001748
Adverse Drug Reaction (ADR). Report number: E2B_03444012.Organization: Health Canada
June 2021
Req # A-2020-001773
Adverse Drug Reaction (ADR). Report number: E2B_03498705.Organization: Health Canada
June 2021
Req # A-2020-001924
Adverse Reaction Reports (AERs) for Abilify. Report numbers: E2B_03452264, E2B_03452286, E2B_03452288, E2B_03452296, E2B_03452301, E2B_03452302, E2B_03452319, E2B_03452360, E2B_03452382, E2B_03452517, E2B_03452588, E2B_03459113, E2B_03459121,…Organization: Health Canada
June 2021
Req # A-2020-001871
Adverse Drug Reaction (ADR) for Leflunomide. Report number: 000726887.Organization: Health Canada
June 2021
Req # A-2018-000572
Adverse reactions/deaths related to caffeinated energy drinks that have been reported to Health Canada from all sources (ex: public, medical community, industry and those forwarded from the Natural Health Product (NHP) database) since January 2013.Organization: Health Canada
June 2020
Req # A-2019-001794
All records on a product presently considered for access by Health Canada's Special Access Program (SAP). The product is KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE INJECTION. From January 01, 2015 to December 31, 2019.Organization: Health Canada
June 2020